Autophagy up-regulated by MEK/ERK promotes the repair of DNA damage caused by aflatoxin B1

References

• Ashraf NU, Sheikh TA. 2015. Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease. Free Radic Res. 49(12):1405–1418.
   PubMed Web of Science ®Google Scholar
• Baldwin AS. 2012. Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer. Immunol Rev. 246(1):327–345.
   PubMedGoogle Scholar
• Cao W, Li J, Yang K, Cao D. 2021. An overview of autophagy: mechanism, regulation and research progress. Bull Cancer. 108(3):304–322.
   PubMed Web of Science ®Google Scholar
• Cao W, Liu X, Zhang Y, Li A, Xie Y, Zhou S, Song L, Xu R, Ma Y, Cai S, et al. 2021. BEZ235 increases the sensitivity of hepatocellular carcinoma to sorafenib by inhibiting PI3K/AKT/mTOR and inducing autophagy. Biomed Res Int. 2021:5556306.
   PubMed Web of Science ®Google Scholar
• Cao W, Zhang Y, Li A, Yu P, Song L, Liang J, Cao N, Gao J, Xu R, Ma Y, et al. 2021. Curcumin reverses hepatic epithelial mesenchymal transition induced by trichloroethylene by inhibiting IL-6R/STAT3. Toxicol Mech Methods. :1–11.
   Web of Science ®Google Scholar
• Chen KL, Chang WS, Cheung CH, Lin CC, Huang CC, Yang YN, Kuo CP, Kuo CC, Chang YH, Liu KJ, Wu CM, Chang JY. 2012. Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway. Cancer Lett. 317(1):89–98.
   PubMed Web of Science ®Google Scholar
• Degola F, Bisceglie F, Pioli M, Palmano S, Elviri L, Pelosi G, Lodi T, Restivo FM. 2017. Structural modification of cuminaldehyde thiosemicarbazone increases inhibition specificity toward aflatoxin biosynthesis and sclerotia development in Aspergillus flavus. Appl Microbiol Biotechnol. 101(17):6683–6696.
   PubMed Web of Science ®Google Scholar
• Duan L, Danzer B, Levenson VV, Maki CG. 2014. Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells. Cancer Lett. 353(2):290–300.
   PubMed Web of Science ®Google Scholar
• Elbatreek MH, Mucke H, Schmidt H. 2021. NOX inhibitors: from bench to naxibs to bedside. Handb Exp Pharmacol. 264:145–168.
   PubMedGoogle Scholar
• Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, Griendling KK. 2018. Reactive oxygen species in metabolic and inflammatory signaling. Circ Res. 122(6):877–902.
   PubMed Web of Science ®Google Scholar
• Gartel AL. 2012. Mechanisms of apoptosis induced by anticancer compounds in melanoma cells. Curr Top Med Chem. 12(1):50–52.
   PubMed Web of Science ®Google Scholar
• Guarini G, Kiyooka T, Ohanyan V, Pung YF, Marzilli M, Chen YR, Chen CL, Kang PT, Hardwick JP, Kolz CL, Yin LY, et al. 2016. Impaired coronary metabolic dilation in the metabolic syndrome is linked to mitochondrial dysfunction and mitochondrial DNA damage. Basic Res Cardiol. 111(3):29.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Dinkova-Kostova AT. 2014. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci. 39(4):199–218.
   PubMed Web of Science ®Google Scholar
• Huang HQ, Ni HF, Ma KL, Zou JH. 2019. ANGPTL2 regulates autophagy through the MEK/ERK/Nrf-1 pathway and affects the progression of renal fibrosis in diabetic nephropathy. Am J Transl Res. 11(9):5472–5486.
   PubMed Web of Science ®Google Scholar
• Jia J, Zhang HB, Shi Q, Yang C, Ma JB, Jin B, Wang X, He D, Guo P. 2019. KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy. Theranostics. 9(19):5464–5477.
   PubMed Web of Science ®Google Scholar
• Jin JK, Blackwood EA, Azizi K, Thuerauf DJ, Fahem AG, Hofmann C, Kaufman RJ, Doroudgar S, Glembotski CC. 2017. ATF6 decreases myocardial ischemia/reperfusion damage and links er stress and oxidative stress signaling pathways in the heart. Circ Res. 120(5):862–875.
   PubMed Web of Science ®Google Scholar
• Letouze E, Shinde J, Renault V, Couchy G, Blanc JF, Tubacher E, Bayard Q, Bacq D, Meyer V, Semhoun J, et al. 2017. Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis. Nat Commun. 8(1):1315.
   PubMedGoogle Scholar
• Li A, Cao W, Liu X, Zhang Y, Ma Y, Xu R, Zhang R, Liu X, Zhou S, Wang R, et al. 2020. Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells. J Cancer Res Clin Oncol. 146(7):1737–1749.
   PubMed Web of Science ®Google Scholar
• Li AM, Cao WY, Liu XK, Zhang YC, Ma YF, Xu RY, Tang XL. 2020. Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells. Transl Cancer Res Tcr. 9(9):5473–5483.
   Web of Science ®Google Scholar
• Li CF, Liu SM, Zheng J, Xue YW. 2021. Angelica sinensis polysaccharide (ASP) attenuates diosbulbin-B (DB)-induced hepatotoxicity through activating the MEK/ERK pathway. Bioengineered. 12(1):3516–3524.
   PubMed Web of Science ®Google Scholar
• Liang Y, Xie CM, Li AM, Huo Z, Wu BQ, Cai SY, Cao WY, Ma YF, Xu RY, Jiang ZY, et al. 2020. Anti-GPC3 antibody-conjugated BEZ235 loaded polymeric nanoparticles (Ab-BEZ235-NP) enhances radiosensitivity in hepatocellular carcinoma cells by inhibition of DNA double-strand break repair. J Biomed Nanotechnol. 16(4):446–455.
   PubMed Web of Science ®Google Scholar
• Ma YF, Xu RY, Liu XK, Zhang YC, Song L, Cai SY, Zhou SP, Xie YH, Li AM, Cao WY, et al. 2021. LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells. Int J Med Sci. 18(6):1456–1464.
   PubMed Web of Science ®Google Scholar
• Muriel P. 2009. Role of free radicals in liver diseases. Hepatol Int. 3(4):526–536.
   PubMed Web of Science ®Google Scholar
• Paul S, Jakhar R, Bhardwaj M, Kang SC. 2015. Glutathione-S-transferase omega 1 (GSTO1-1) acts as mediator of signaling pathways involved in aflatoxin B1-induced apoptosis-autophagy crosstalk in macrophages. Free Radic Biol Med. 89:1218–1230.
   PubMed Web of Science ®Google Scholar
• Perez-Gonzalez A, Castaneda-Arriaga R, Alvarez-Idaboy JR, Reiter RJ, Galano A. 2019. Melatonin and its metabolites as chemical agents capable of directly repairing oxidized DNA. J Pineal Res. 66(2):e12539.
   PubMed Web of Science ®Google Scholar
• Rogers MA, Maldonado N, Hutcheson JD, Goettsch C, Goto S, Yamada I, Faits T, Sesaki H, Aikawa M, Aikawa E. 2017. Dynamin-related protein 1 inhibition attenuates cardiovascular calcification in the presence of oxidative stress. Circ Res. 121(3):220–233.
   PubMed Web of Science ®Google Scholar
• Rotimi OA, Rotimi SO, Goodrich JM, Adelani IB, Agbonihale E, Talabi G. 2019. Time-course effects of acute aflatoxin b1 exposure on hepatic mitochondrial lipids and oxidative stress in rats. Front Pharmacol. 10:467.
   PubMed Web of Science ®Google Scholar
• Rushing BR, Selim MI. 2019. Aflatoxin B1: A review on metabolism, toxicity, occurrence in food, occupational exposure, and detoxification methods. Food Chem Toxicol. 124:81–100.
   PubMed Web of Science ®Google Scholar
• Salwa A, Ferraresi A, Chinthakindi M, Vallino L, Vidoni C, Dhanasekaran DN, Isidoro C. 2021. BECN1 and BRCA1 deficiency sensitizes ovarian cancer to platinum therapy and confers better prognosis. Biomedicines. 9(2):207.
   PubMed Web of Science ®Google Scholar
• Schlenker T, Schwake L, Voss A, Stremmel W, Elsing C. 2015. Oxidative stress activates membrane ion channels in human biliary epithelial cancer cells (Mz-Cha-1). Anticancer Res. 35(11):5881–5888.
   PubMed Web of Science ®Google Scholar
• Sciarretta S, Forte M, Frati G, Sadoshima J. 2018. New insights into the role of mTOR signaling in the cardiovascular system. Circ Res. 122(3):489–505.
   PubMed Web of Science ®Google Scholar
• Shah MS, Brownlee M. 2016. Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res. 118(11):1808–1829.
   PubMed Web of Science ®Google Scholar
• Shen J, Cai W, Ma Y, Xu R, Huo Z, Song L, Qiu X, Zhang Y, Li A, Cao W, et al. 2020. hGC33-modified and sorafenib-loaded nanoparticles have a synergistic anti-hepatoma effect by inhibiting Wnt signaling pathway. Nanoscale Res Lett. 15(1):220.
   PubMed Web of Science ®Google Scholar
• Smela ME, Hamm ML, Henderson PT, Harris CM, Harris TM, Essigmann JM. 2002. The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. Proc Natl Acad Sci USA. 99(10):6655–6660.
   PubMed Web of Science ®Google Scholar
• Souto NS, Braga ACM, De Freitas ML, Fighera MR, Royes LFF, Oliveira MS, Furian AF. 2018. Aflatoxin B1 reduces non-enzymatic antioxidant defenses and increases protein kinase C activation in the cerebral cortex of young rats. Nutr Neurosci. 21(4):268–275.
   PubMed Web of Science ®Google Scholar
• Stankovic-Valentin N, Melchior F. 2018. Control of SUMO and ubiquitin by ROS: signaling and disease implications. Mol Aspects Med. 63:3–17.
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Ko R, Goshima H, Koike A, Shibano M, Fujimori K. 2021. Formononetin attenuates H2O2-induced cell death through decreasing ROS level by PI3K/Akt-Nrf2-activated antioxidant gene expression and suppressing MAPK-regulated apoptosis in neuronal SH-SY5Y cells. Neurotoxicology. 85:186–200.
   PubMed Web of Science ®Google Scholar
• Wang B, Chen Y, Wu Y, Weng B, Liu Y, Lu Z, Li CM, Yu C. 2016. Aptamer induced assembly of fluorescent nitrogen-doped carbon dots on gold nanoparticles for sensitive detection of AFB1. Biosens Bioelectron. 78:23–30.
   PubMed Web of Science ®Google Scholar
• Wang G, Xi Y, Lian C, Sun Z, Zheng S. 2019. Simultaneous detoxification of polar aflatoxin B1 and weak polar zearalenone from simulated gastrointestinal tract by zwitterionic montmorillonites. J Hazard Mater. 364:227–237.
   PubMed Web of Science ®Google Scholar
• Wang Y, Nie H, Zhao X, Qin Y, Gong XG. 2016. Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K/AKT and Ras/Raf/MEK/ERK pathways. BMC Cancer. 16(1):742.
   Google Scholar
• Wedemeyer H, Dore GJ, Ward JW. 2015. Estimates on HCV disease burden worldwide - filling the gaps. J Viral Hepat. 22(Suppl 1):1–5.
   PubMed Web of Science ®Google Scholar
• Wijshake T, Zou Z, Chen B, Zhong L, Xiao G, Xie Y, Doench JG, Bennett L, Levine B. 2021. Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin. Proc Natl Acad Sci USA. 118(5).
   PubMed Web of Science ®Google Scholar
• Xu R, Zhang Y, Li A, Ma Y, Cai W, Song L, Xie Y, Zhou S, Cao W, Tang X. 2021. LY294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF1alpha pathway. Mol Med Rep. 24(1):508.
   Web of Science ®Google Scholar
• Xue M, Yang F, Le Y, Yang Y, Wang B, Jia Y, Zheng Z, Xue Y. 2021. Klotho protects against diabetic kidney disease via AMPK- and ERK-mediated autophagy. Acta Diabetol.
   Web of Science ®Google Scholar
• Zhang XY, Zhang M, Cong Q, Zhang MX, Zhang MY, Lu YY, Xu CJ. 2018. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy. Int J Biochem Cell Biol. 95:9–16.
   PubMed Web of Science ®Google Scholar
• Zhang YC, Wu CG, Li AM, Liang Y, Ma D, Tang XL. 2021. Oxaliplatin and gedatolisib (PKI-587) Co-loaded hollow polydopamine nano-shells with simultaneous upstream and downstream action to re-sensitize drugs-resistant hepatocellular carcinoma to chemotherapy. J Biomed Nanotechnol. 17(1):18–36.
   PubMed Web of Science ®Google Scholar
• Zhou SP, Ma YF, Liu XK, Yu P, Huang N, Song L, Xu RY, Huo Z, Zhu T, Tang XL. 2021. Targeted delivery of glypican 3 (GPC3) antibody-modified microRNA (miR let-7b-5p) polymer nanoparticles to sorafenib-resistant hepatsocellular carcinoma cells. J Biomed Nanotechnol. 17(4):677–690.
   PubMed Web of Science ®Google Scholar